Back to today’s briefing

Story perspectives

Congress Unites to Combat Drug Prices Amid PBM Dominance

6/29/2025

50 5

Summary

Story summary

Congress is uniting across party lines to tackle soaring drug prices by focusing on Pharmacy Benefit Managers (PBMs), who dominate 80% of the market. Experts warn that without addressing PBMs' influence, proposed reforms may fall short. Meanwhile, independent pharmacies struggle with dwindling reimbursements and Medicaid regulations, spurring Virginia to push for legislative improvements.

1 of 1

Story summary

Congress is uniting across party lines to tackle soaring drug prices by focusing on Pharmacy Benefit Managers (PBMs), who dominate 80% of the market. Experts warn that without addressing PBMs' influence, proposed reforms may fall short. Meanwhile, independent pharmacies struggle with dwindling reimbursements and Medicaid regulations, spurring Virginia to push for legislative improvements.